Skip to content

SuperSTAT Noninvasive Blood Pressure Monitor Evaluation

SuperSTAT Noninvasive Blood Pressure Monitor Evaluation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00603486
Enrollment
20
Registered
2008-01-29
Start date
2007-11-30
Completion date
2008-07-31
Last updated
2008-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Invasive Blood Pressure

Keywords

Non-invasive Blood Pressure (NIBP), GE Dinamap, SuperSTAT

Brief summary

The accuracy and/or performance of the GE DINAMAP noninvasive blood pressure (NIBP) monitors may be improved with modifications in software and/or hardware monitoring techniques and/or accessories. When changes are being made to the GE Monitor, testing can be done to evaluate performance of the investigational devices during and/or after product development.

Interventions

DEVICEGE DINAMAP with SuperSTAT algorithm monitor

Apply cuff on a limb, cuff is inflated and deflated, monitor will displays non-invasive blood pressure values (systolic, diastolic, MAP, and pulse rate)

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Years
Healthy volunteers
Yes

Inclusion criteria

* Signed informed consent * Ability to single or dual monitor NIBP, ECG, and/or SpO2, whether or not already being monitored for any or all of these parameters.

Exclusion criteria

* Any subject deemed too unstable, at the clinician's discretion, to participate in the study * Any subject with a cardiac anomaly that would cause a disparity between aortic pressures and the periphery. * Any subject who cannot tolerate, in the opinion of the clinician, multiple blood pressure measurements * Known disease state or medical condition that A) compromises circulation to the extremity (ies), B) compromises musculo-skeletal integrity, or C) otherwise contraindicates use of a NIBP cuff and/or SpO2 sensor on an extremity or ECG patches on skin * Excessive movement or excitability causing false values or no determinations (SP10 accuracy study only)

Design outcomes

Primary

MeasureTime frame
Evaluation of one of the GE DINAMAP NIBP Monitor algorithms, SuperSTAT NIBP, in neonatal and/or infant subjects.1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026